Gimv discontinuing new investments in life sciences platform
European investment firm Gimv announced a significant strategic pivot on Monday, January 26, declaring it will discontinue all new investments in its life sciences platform. This decision marks a shift in focus toward four core investment pillars: consumer, healthcare, smart industries, and sustainable cities, where the firm identifies significant growth opportunities linked to the digital transition. For healthcare operators and investors, this move signals a…